Assisted Reproductive Medicine in China

China's rapid growth has provided great opportunities for young people to pursue self-development, which has resulted in a delay in childbearing and an increase in the infertility rate among Chinese couples of childbearing age, owing to various factors. With the introduction of the two-child policy, demand for assisted reproductive technology among Chinese couples is increasing, creating a huge market. China will continue to lead the global market in assisted reproduction.

Swiss International Health Care has partnered with leading institutions in Europe and China to establish its own IVF brand and state-of-the-art egg and ovarian tissue freezing and storage facilities in China.

Swiss International Health Care GmbH

Winkelriedstrasse 82
8203 Schaffhausen

Legal information